Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Bernstein

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Human Mutation|October 21, 2010
How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010Maija R J Kohonen-Corish, Jumana Y Al-Aama, Arleen D Auerbach, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Lynch syndrome caused by germline PMS2 mutations: delineating the cancer riskSanne W ten Broeke, Richard M Brohet, Carli M Tops, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 26, 2015
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriersManon Suerink, Heleen M van der Klift, Sanne W Ten Broeke, et al.
Gut|December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut|February 15, 2013
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsHans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, et al.
Gut|June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Hereditary Cancer in Clinical Practice|October 20, 2017
Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database reportToni Seppälä, Kirsi Pylvänäinen, Dafydd Gareth Evans, et al.
Gut|July 30, 2017
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome DatabasePål Møller, Toni T Seppälä, Inge Bernstein, et al.
Hereditary Cancer in Clinical Practice|October 23, 2019
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reportMev Dominguez-Valentin, Toni T Seppälä, Julian R Sampson, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Human Mutation|October 21, 2010
How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010Maija R J Kohonen-Corish, Jumana Y Al-Aama, Arleen D Auerbach, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Lynch syndrome caused by germline PMS2 mutations: delineating the cancer riskSanne W ten Broeke, Richard M Brohet, Carli M Tops, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 26, 2015
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriersManon Suerink, Heleen M van der Klift, Sanne W Ten Broeke, et al.
Gut|December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut|February 15, 2013
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsHans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, et al.
Gut|June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Hereditary Cancer in Clinical Practice|October 20, 2017
Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database reportToni Seppälä, Kirsi Pylvänäinen, Dafydd Gareth Evans, et al.
Gut|July 30, 2017
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome DatabasePål Møller, Toni T Seppälä, Inge Bernstein, et al.
Hereditary Cancer in Clinical Practice|October 23, 2019
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reportMev Dominguez-Valentin, Toni T Seppälä, Julian R Sampson, et al.
Pageof 8